Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Vascular Surgery

  Free Subscription


Articles published in Thromb Haemost

Retrieve available abstracts of 35 articles:
HTML format



Single Articles


    June 2024
  1. CATTANEO M, Squizzato A, Birocchi S, Podda GM, et al
    Guided Anti-P2Y12 Therapy in Patients Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2024;124:595-597.
    PubMed    


  2. UEKI Y, Haner JD, Losdat S, Gargiulo G, et al
    Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial.
    Thromb Haemost. 2024;124:517-527.
    PubMed     Abstract available


    May 2024
  3. LANDOLINA D, Ammirabile N, Capodanno D
    Strategies for Tailored Antiplatelet Therapy after Percutaneous Coronary Intervention: Unraveling Complexities, Embracing Nuances.
    Thromb Haemost. 2024;124:497-499.
    PubMed    


  4. BIROCCHI S, Rocchetti M, Minardi A, Podda GM, et al
    Guided Anti-P2Y12 Therapy in Patients Undergoing PCI: Three Systematic Reviews with Meta-analyses of Randomized Controlled Trials with Homogeneous Design.
    Thromb Haemost. 2024;124:482-496.
    PubMed     Abstract available


    March 2024
  5. ORTEGA-PAZ L, Franchi F, Rollini F, Galli M, et al
    Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.
    Thromb Haemost. 2024;124:263-273.
    PubMed     Abstract available


    October 2023
  6. PEDERSEN OB, Hvas AM, Pasalic L, Kristensen SD, et al
    Platelet Function and Maturity and Related microRNA Expression in Whole Blood in Patients with ST-Segment Elevation Myocardial Infarction.
    Thromb Haemost. 2023 Oct 16. doi: 10.1055/s-0043-1776305.
    PubMed     Abstract available


    September 2023
  7. BONGIOVANNI D, Novelli L, Condello F, Kirmes K, et al
    Reticulated Platelets Predict Cardiovascular Death and Adverse Events in Coronary Artery Disease: A Systematic Review and Meta-analysis.
    Thromb Haemost. 2023 Sep 11. doi: 10.1055/s-0043-1773763.
    PubMed     Abstract available


    August 2023
  8. HE HM, Chen YN, Zeng JL, Zheng SW, et al
    The Prognostic Value of the Age-D-Dimer-Albumin Score in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2023 Aug 29. doi: 10.1055/s-0043-1773764.
    PubMed     Abstract available


  9. LAHU S, Adler K, Mayer K, Hein-Rothweiler R, et al
    Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary Intervention.
    Thromb Haemost. 2023 Aug 17. doi: 10.1055/s-0043-1772221.
    PubMed     Abstract available


  10. GOROG DA, Jeyalan V, Markides RIL, Navarese EP, et al
    Comparison of De-escalation of DAPT Intensity or Duration in East Asian and Western Patients with ACS Undergoing PCI: A Systematic Review and Meta-analysis.
    Thromb Haemost. 2023;123:773-792.
    PubMed     Abstract available


    June 2023
  11. SONG H, Ahn JH, Kang MG, Kim KH, et al
    Post-PCI Risk Assessment by Inflammation Activity According to Disease Acuity and Time from Procedure.
    Thromb Haemost. 2023;123:627-640.
    PubMed     Abstract available


    December 2022
  12. VERHEUGT FWA, Huber K, Clemmensen P, Collet JP, et al
    Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation.
    Thromb Haemost. 2022 Dec 30. doi: 10.1055/s-0042-1755330.
    PubMed     Abstract available


    November 2022
  13. KOCH T, Lahu S, Coughlan JJ, Cassese S, et al
    Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
    Thromb Haemost. 2022 Nov 28. doi: 10.1055/a-1988-5047.
    PubMed     Abstract available


    October 2022
  14. ROONGSANGMANOON W, Chichareon P, Angkananard T, Suwannasom P, et al
    External validation of ACUITY/HORIZON bleeding risk score among acute coronary syndrome patients in Thai PCI Registry.
    Thromb Haemost. 2022 Oct 20. doi: 10.1055/a-1964-8247.
    PubMed     Abstract available


    September 2022
  15. RIKKEN SAOF, Storey RF, Andreotti F, Clemmensen P, et al
    Parenteral Antiplatelet Drugs in ST-Elevation Myocardial Infarction: Current Status and Future Directions.
    Thromb Haemost. 2022 Sep 8. doi: 10.1055/s-0042-1753479.
    PubMed     Abstract available


    May 2022
  16. ZHANG Y, Zhang Y, Shi X, Lin B, et al
    Clopidogrel versus Ticagrelor in CYP2C19 Loss-of-Function Allele Noncarriers: A Real-World Study in China.
    Thromb Haemost. 2022;122:842-852.
    PubMed     Abstract available


    April 2022
  17. PATTI G, Grisafi L, Spinoni E, Rognoni A, et al
    Safety and efficacy of selective, clopidogrel-based strategies in acute coronary syndrome: a study-level meta-analysis.
    Thromb Haemost. 2022 Apr 18. doi: 10.1055/a-1827-8041.
    PubMed     Abstract available


  18. GROSSE GM, Werlein C, Blume N, Abu-Fares O, et al
    Circulating Cytokines and Growth Factors in Acute Cerebral Large Vessel Occlusion-Association with Success of Endovascular Treatment.
    Thromb Haemost. 2022;122:623-632.
    PubMed     Abstract available


    March 2022
  19. MALY M, Riedel T, Stikarova J, Suttnar J, et al
    Incorporation of Fibrin, Platelets, and Red Blood Cells into a Coronary Thrombus in Time and Space.
    Thromb Haemost. 2022;122:434-444.
    PubMed     Abstract available


  20. KITANO T, Hori Y, Okazaki S, Shimada Y, et al
    An Older Thrombus Delays Reperfusion after Mechanical Thrombectomy for Ischemic Stroke.
    Thromb Haemost. 2022;122:415-426.
    PubMed     Abstract available


    January 2022
  21. CHAO TF, Joung B, Takahashi Y, Lim TW, et al
    2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.
    Thromb Haemost. 2022;122:20-47.
    PubMed     Abstract available


    November 2021
  22. BLASCO A, Coronado MJ, Vela P, Martin P, et al
    Prognostic implications of Neutrophil Extracellular Traps in coronary thrombi of patients with ST-elevation myocardial infarction.
    Thromb Haemost. 2021 Nov 30. doi: 10.1055/a-1709-5271.
    PubMed     Abstract available


    October 2021
  23. SCHUCHARDT FF, Demerath T, Elsheikh S, Wehrum T, et al
    Dural Arteriovenous Fistula Formation Secondary to Cerebral Venous Thrombosis: Longitudinal Magnetic Resonance Imaging Assessment Using 4D-Combo-MR-Venography.
    Thromb Haemost. 2021;121:1345-1352.
    PubMed     Abstract available


    September 2021
  24. MONTALTO C, Crimi G, Morici N, Palmerini T, et al
    Validation and Additive Predictive Value of the Academic Research Consortium-High Bleeding Risk Criteria in Older Adults.
    Thromb Haemost. 2021;121:1255-1257.
    PubMed    


    May 2021
  25. COLE O
    Atrial Fibrillation After Cardiac Surgery - To Infinity and Beyond!
    Thromb Haemost. 2021 May 11. doi: 10.1055/a-1506-8744.
    PubMed     Abstract available


    March 2021
  26. FABRIS E, Korjian S, Coller B, Ten Berg JM, et al
    Pre-Hospital Antiplatelet Therapy for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: What We Know and What Lies Ahead.
    Thromb Haemost. 2021 Mar 7. doi: 10.1055/a-1414-5009.
    PubMed     Abstract available


    January 2021
  27. GUEDENEY P, Collet JP
    Antithrombotic Therapy in Acute Coronary Syndromes: Current Evidence and Ongoing Issues Regarding Early and Late Management.
    Thromb Haemost. 2021 Jan 27. doi: 10.1055/s-0040-1722188.
    PubMed     Abstract available


  28. MANDROLA JM, Kaul S, Foy A
    Lessons Learnt from Recent Trials in Ischemic Heart Disease.
    Thromb Haemost. 2021;121:8-14.
    PubMed     Abstract available


    December 2020
  29. AZNAOURIDIS K, Tselegkidi ME, Kanakakis I, Alexopoulos D, et al
    Dual Antithrombotic Therapy in Atrial Fibrillation Patients undergoing Percutaneous Coronary Angioplasty: The Impact of Bleeding Risk Score on Outcome.
    Thromb Haemost. 2020 Dec 30. doi: 10.1055/s-0040-1721777.
    PubMed    


  30. LAINE M, Panagides V, Frere C, Cuisset T, et al
    On-ticagrelor platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
    Thromb Haemost. 2020 Dec 1. doi: 10.1055/a-1326-5110.
    PubMed     Abstract available


    November 2020
  31. MONTALTO C, Ferlini M, Casula M, Mandurino-Mirizzi A, et al
    DAPT Score to Stratify Ischemic and Bleeding Risk after Percutaneous Coronary Intervention: An Updated Systematic Review, Meta-Analysis, and Meta-Regression of 100,211 Patients.
    Thromb Haemost. 2020 Nov 19. doi: 10.1055/s-0040-1721145.
    PubMed    


    October 2020
  32. ZHENG YY, Wu TT, Gao Y, Guo QQ, et al
    A Novel ABC Score Predicts Mortality in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Who underwent Percutaneous Coronary Intervention.
    Thromb Haemost. 2020 Oct 31. doi: 10.1055/s-0040-1718411.
    PubMed     Abstract available


    July 2020
  33. FERNANDO H, McFadyen JD, Palasubramaniam J, Shaw J, et al
    Antithrombotic Therapy in Myocardial Infarction: Historic Perils and Current Challenges-A 70-Year Journey.
    Thromb Haemost. 2020 Jul 24. doi: 10.1055/s-0040-1714212.
    PubMed     Abstract available


  34. LIU Z, Tian R, Wang Y, Chen Q, et al
    Platelet Inhibition with Ticagrelor versus Clopidogrel in Diabetic Patients after Percutaneous Coronary Intervention for Chronic Coronary Syndromes.
    Thromb Haemost. 2020 Jul 15. doi: 10.1055/s-0040-1713375.
    PubMed     Abstract available


    June 2020
  35. KAZEM N, Sulzgruber P, Thaler B, Baumgartner J, et al
    CD8+CD28null T Lymphocytes are Associated with the Development of Atrial Fibrillation after Elective Cardiac Surgery.
    Thromb Haemost. 2020 Jun 28. doi: 10.1055/s-0040-1713096.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vascular Surgery is free of charge.